Metraipolis › archive › dc_ad1be0705e72
MDM2-amplified esophageal adenocarcinomas exhibit an activated metabolic and immunosuppressive phenotype with multiple potential therapeutic targets — Europe PMC PMID:41299419
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41299419
- DOI
- 10.1186/s12885-[numero omesso]-3
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-08T06:08:17.054Z
- SHA-256 of the archived text
76a3827ed00340e7ee42435bfaa533abc58d0a86444eeef61df08b6e4d86532f- Stable URL of this page
https://metraipolis.com/documento/dc_ad1be0705e72
How to cite
MDM2-amplified esophageal adenocarcinomas exhibit an activated metabolic and immunosuppressive phenotype with multiple potential therapeutic targets — Europe PMC PMID:41299419 — Europe PMC (en), https://europepmc.org/article/MED/41299419 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ad1be0705e72 (Metraipolis archive dc_ad1be0705e72, sha256 76a3827ed00340e7ee42435bfaa533abc58d0a86444eeef61df08b6e4d86532f)
BibTeX
@misc{dcad1be0705e72,
title = {MDM2-amplified esophageal adenocarcinomas exhibit an activated metabolic and immunosuppressive phenotype with multiple potential therapeutic targets — Europe PMC PMID:41299419},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41299419},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ad1be0705e72; sha256 76a3827ed00340e7ee42435bfaa533abc58d0a86444eeef61df08b6e4d86532f},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41299419. Agents can read the archived copy with the MCP tool read_document.